Ally Bridge Group

Latest statistics and disclosures from Ally Bridge Group's latest quarterly 13F-HR filing:

Tip: Access up to 7 years of quarterly data

Positions held by Ally Bridge Group consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Portfolio Holdings for Ally Bridge Group

Ally Bridge Group holds 19 positions in its portfolio as reported in the September 2023 quarterly 13F filing

Company (Ticker) Portfolio Weight Valued At Change in Shares Share Count Share Price
Moonlake Immunotherapeutics Class A Ord (MLTX) 12.3 $10M +100% 183k 57.00
 View chart
Xenon Pharmaceuticals (XENE) 10.7 $9.1M 267k 34.16
 View chart
Intra Cellular Therapies (ITCI) 10.7 $9.1M NEW 175k 52.09
 View chart
Axsome Therapeutics (AXSM) 9.1 $7.7M NEW 111k 69.89
 View chart
Apellis Pharmaceuticals (APLS) 8.1 $6.9M NEW 182k 38.04
 View chart
Cytokinetics Com New (CYTK) 7.7 $6.6M 223k 29.46
 View chart
Merus N V (MRUS) 6.1 $5.2M +11% 221k 23.58
 View chart
Amylyx Pharmaceuticals (AMLX) 5.9 $5.0M NEW 273k 18.31
 View chart
Geron Corporation (GERN) 5.5 $4.7M +4% 2.2M 2.12
 View chart
Ardelyx (ARDX) 4.2 $3.6M NEW 881k 4.08
 View chart
Ambrx Biopharma Sponsored Ads 3.8 $3.2M NEW 281k 11.50
 View chart
Mirati Therapeutics (MRTX) 3.6 $3.1M NEW 70k 43.56
 View chart
Jasper Therapeutics 2.6 $2.2M +24% 3.1M 0.70
 View chart
Black Diamond Therapeutics (BDTX) 2.1 $1.8M -20% 634k 2.87
 View chart
Praxis Precision Medicines I 2.1 $1.8M -66% 1.1M 1.71
 View chart
Compass Therapeutics (CMPX) 2.1 $1.8M 915k 1.97
 View chart
Context Therapeutics (CNTX) 1.3 $1.1M +11% 726k 1.51
 View chart
Promis Neurosciences Com New (PMN) 1.2 $1.1M NEW 532k 1.98
 View chart
Medavail Holdings Com New (MDVL) 0.8 $707k NEW 118k 6.00
 View chart

Past Filings by Ally Bridge Group

SEC 13F filings are viewable for Ally Bridge Group going back to 2020